Drug Development

Listings
  • Anti-CD22 (clone RFB4)-Mc-VC-PABC-MMAF ADC

    Anti-CD22 (clone RFB4)-Mc-VC-PABC-MMAF ADC

    Drug Development Shirley (New York) November 13, 2017 Check with publisher

    This ADC product is comprised of an anti-CD22 monoclonal antibody (clone RFB4) conjugated via a Mc-VC-PABC linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis....

  • Anti-CD22 (clone RFB4)-Mc-MMAF ADC

    Anti-CD22 (clone RFB4)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 13, 2017 Check with publisher

    This ADC product is comprised of an anti-CD22 monoclonal antibody (clone RFB4) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within ...

  • Anti-CD22 (clone RFB4)-Mc-VC-PABC-MMAE ADC

    Anti-CD22 (clone RFB4)-Mc-VC-PABC-MMAE ADC

    Drug Development New York (New York) November 13, 2017 Check with publisher

    This ADC product is comprised of an anti-CD22 monoclonal antibody (clone RFB4) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis....

  • Anti-CD22 (clone 10F4v3)-Mc-VC-PABC-MMAE ADC

    Anti-CD22 (clone 10F4v3)-Mc-VC-PABC-MMAE ADC

    Drug Development Shirley (New York) November 13, 2017 Check with publisher

    This ADC product is comprised of an anti-CD22 monoclonal antibody (clone 10F4v3) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosi...

  • Anti-CD22 (clone 10F4v1)-Mc-MMAF ADC

    Anti-CD22 (clone 10F4v1)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 13, 2017 Check with publisher

    This ADC product is comprised of an anti-CD22 monoclonal antibody (clone 10F4v1) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Withi...

  • Anti-CD22 (clone 10F4v3)-Mc-VC-PABC-MMAE ADC

    Anti-CD22 (clone 10F4v3)-Mc-VC-PABC-MMAE ADC

    Drug Development Shirley (New York) November 13, 2017 Check with publisher

    This ADC product is comprised of an anti-CD22 monoclonal antibody (clone 10F4v3) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosi...

  • Anti-CD22 (10F4v3)-Mc-VC-PABC-MMAE ADC

    Anti-CD22 (10F4v3)-Mc-VC-PABC-MMAE ADC

    Drug Development Shirley (New York) November 13, 2017 Check with publisher

    This ADC product is comprised of an anti-CD22 monoclonal antibody (clone 10F4v3) conjugated via a Mc-VC-PABC linker to MMAE. The MMAE is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosi...

  • Anti-CD22 (10F4v3)-Mc-MMAF ADC

    Anti-CD22 (10F4v3)-Mc-MMAF ADC

    Drug Development Shirley (New York) November 13, 2017 Check with publisher

    This ADC product is comprised of an anti-CD22 monoclonal antibody (clone 10F4v3) conjugated via a Mc linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Withi...

  • Anti-CD22 (clone RFB4)-MCC-DM1 ADC

    Anti-CD22 (clone RFB4)-MCC-DM1 ADC

    Drug Development Shirley (New York) November 13, 2017 Check with publisher

    This ADC product is comprised of an anti-CD22 monoclonal antibody (clone RFB4) conjugated via a MCC linker to a DM1. The DM1 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within...

  • Anti-CD22 (clone 10F4)-AcBut-Calicheamicin ADC

    Anti-CD22 (clone 10F4)-AcBut-Calicheamicin ADC

    Drug Development Shirley (New York) November 13, 2017 Check with publisher

    This ADC product is comprised of an anti-CD22 monoclonal antibody (clone 10F4) conjugated via a AcBut linker to a Calicheamicin. The Calicheamicin is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediat...

  • Anti-CD22 (Epratuzumab)-CL2A-SN-38 ADC

    Anti-CD22 (Epratuzumab)-CL2A-SN-38 ADC

    Drug Development Shirley (New York) November 13, 2017 Check with publisher

    This ADC product is comprised of an a Epratuzumab conjugated via a CL2A linker to a SN-38.The SN-38 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis.The SN-38 is targeted to certain...

  • Anti-CD22 (Epratuzumab)-CL2E-SN-38 ADC

    Anti-CD22 (Epratuzumab)-CL2E-SN-38 ADC

    Drug Development Shirley (New York) November 13, 2017 Check with publisher

    This ADC product is comprised of an a Epratuzumab conjugated via a CL2E linker to a SN-38. The SN-38 is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. The SN-38 is targeted to certa...